Extracellular Vesicle-encapsulated MicroRNA-296-3p from Cancer-associated Fibroblasts Promotes Ovarian Cancer Development Through Regulation of the PTEN/AKT and SOCS6/STAT3 Pathways

Overview

Journal Cancer Sci

Specialty Oncology

Date 2023 Nov 16

PMID 37972389

Authors

Luyao Sun

Miaola Ke

Mengyuan Yin

Ying Zeng

Yutong Ji

Yiming Hu

Songbin Fu

Chunyu Zhang

Affiliations

Soon will be listed here.

Abstract

Cancer-associated fibroblasts (CAFs), as important components of the tumor microenvironment, can regulate intercellular communication and tumor development by secreting extracellular vesicles (EVs). However, the role of CAF-derived EVs in ovarian cancer has not been fully elucidated. Here, using an EV-microRNA sequencing analysis, we reveal specific overexpression of microRNA (miR)-296-3p in activated CAF-derived EVs, which can be transferred to tumor cells to regulate the malignant phenotypes of ovarian cancer cells. Moreover, overexpression of miR-296-3p significantly promotes the proliferation, migration, invasion, and drug resistance of ovarian cancer cells in vitro, as well as tumor growth in vivo, while its inhibition has the opposite effects. Further mechanistic studies reveal that miR-296-3p promotes ovarian cancer progression by directly targeting PTEN and SOCS6 and activating AKT and STAT3 signaling pathways. Importantly, increased expression of miR-296-3p encapsulated in plasma EVs is closely correlated with tumorigenesis and chemoresistance in patients with ovarian cancer. Our results highlight the cancer-promoting role of CAF-derived EVs carrying miR-296-3p in ovarian cancer progression for the first time, and suggest that miR-296-3p encapsulated in CAF-derived EVs could be a diagnostic biomarker and therapeutic target for ovarian cancer.

Citing Articles

Advances in small extracellular vesicles: roles in the tumor microenvironment and epithelial ovarian cancer diagnosis and treatment.

Peng L, Lai Y, Cao B Front Oncol. 2025; 15:1526944.

PMID: 40008006 PMC: 11850269. DOI: 10.3389/fonc.2025.1526944.

Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy.

Zhang Z, Wang R, Chen L Int J Nanomedicine. 2025; 20():483-503.

PMID: 39816375 PMC: 11734509. DOI: 10.2147/IJN.S500591.

Ovarian tumor microenvironment contributes to tumor progression and chemoresistance.

Ponton-Almodovar A, Sanderson S, Rattan R, Bernard J, Horibata S Cancer Drug Resist. 2025; 7():53.

PMID: 39802952 PMC: 11724355. DOI: 10.20517/cdr.2024.111.

Upregulation of miRNA-450b-5p targets ACTB to affect drug resistance and prognosis of ovarian cancer via the PI3K/Akt signaling pathway.

Xie S, Su Y, Zhang J, Yin F, Liu X Transl Cancer Res. 2024; 13(9):4800-4812.

PMID: 39430863 PMC: 11483453. DOI: 10.21037/tcr-24-292.

Chemoresistance and the tumor microenvironment: the critical role of cell-cell communication.

Wilczynski B, Dabrowska A, Kulbacka J, Baczynska D Cell Commun Signal. 2024; 22(1):486.

PMID: 39390572 PMC: 11468187. DOI: 10.1186/s12964-024-01857-7.

References

Chalhoub N, Baker S . PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2008; 4:127-50. PMC: 2710138. DOI: 10.1146/annurev.pathol.4.110807.092311. View

Shan G, Zhou X, Gu J, Zhou D, Cheng W, Wu H . Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN. Cell Oncol (Dordr). 2021; 44(1):45-59. PMC: 7906940. DOI: 10.1007/s13402-020-00500-0. View

Sun Z, Liu Q, Hong H, Zhang H, Zhang T . miR-19 promotes osteosarcoma progression by targeting SOCS6. Biochem Biophys Res Commun. 2017; 495(1):1363-1369. DOI: 10.1016/j.bbrc.2017.10.002. View

Liang R, Chen X, Chen L, Wan F, Chen K, Sun Y . STAT3 signaling in ovarian cancer: a potential therapeutic target. J Cancer. 2020; 11(4):837-848. PMC: 6959025. DOI: 10.7150/jca.35011. View

Laudisi F, Cherubini F, Monteleone G, Stolfi C . STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment. Int J Mol Sci. 2018; 19(6). PMC: 6032216. DOI: 10.3390/ijms19061787. View

Wang H, Wei H, Wang J, Li L, Chen A, Li Z . MicroRNA-181d-5p-Containing Exosomes Derived from CAFs Promote EMT by Regulating CDX2/HOXA5 in Breast Cancer. Mol Ther Nucleic Acids. 2020; 19:654-667. PMC: 6970169. DOI: 10.1016/j.omtn.2019.11.024. View

Wang X, Qin X, Yan M, Shi J, Xu Q, Li Z . Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression. J Exp Clin Cancer Res. 2019; 38(1):151. PMC: 6454737. DOI: 10.1186/s13046-019-1144-9. View

Lai R, Hsiao Y, Wang M, Lin H, Wu C, Chi C . SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation. Cancer Lett. 2009; 288(1):75-85. DOI: 10.1016/j.canlet.2009.06.025. View

Zhang L, Ma T, Brozick J, Babalola K, Budiu R, Tseng G . Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer. Oncogene. 2016; 35(38):5010-20. PMC: 5023457. DOI: 10.1038/onc.2016.53. View

10.

Munir J, Yoon J, Ryu S . Therapeutic miRNA-Enriched Extracellular Vesicles: Current Approaches and Future Prospects. Cells. 2020; 9(10). PMC: 7601381. DOI: 10.3390/cells9102271. View

11.

Han Q, Tan S, Gong L, Li G, Wu Q, Chen L . Omental cancer-associated fibroblast-derived exosomes with low microRNA-29c-3p promote ovarian cancer peritoneal metastasis. Cancer Sci. 2023; 114(5):1929-1942. PMC: 10154903. DOI: 10.1111/cas.15726. View

12.

Shi L, Zhu W, Huang Y, Zhuo L, Wang S, Chen S . Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer. Clin Transl Med. 2022; 12(7):e989. PMC: 9299573. DOI: 10.1002/ctm2.989. View

13.

Qiu X, Zheng J, Guo X, Gao X, Liu H, Tu Y . Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis. Mol Cell Biochem. 2013; 378(1-2):99-106. DOI: 10.1007/s11010-013-1599-5. View

14.

He C, Wang L, Li L, Zhu G . Extracellular vesicle-orchestrated crosstalk between cancer-associated fibroblasts and tumors. Transl Oncol. 2021; 14(12):101231. PMC: 8493591. DOI: 10.1016/j.tranon.2021.101231. View

15.

Yeung C, Co N, Tsuruga T, Yeung T, Kwan S, Leung C . Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun. 2016; 7:11150. PMC: 4820618. DOI: 10.1038/ncomms11150. View

16.

M J, S V . BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer. Gene. 2018; 678:302-311. DOI: 10.1016/j.gene.2018.08.022. View

17.

Yoon S, Yi Y, Kim S, Kim J, Park W, Nam S . SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues. Tumour Biol. 2011; 33(1):215-21. DOI: 10.1007/s13277-011-0264-4. View

18.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

19.

Matsumura T, Sugimachi K, Iinuma H, Takahashi Y, Kurashige J, Sawada G . Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer. 2015; 113(2):275-81. PMC: 4506387. DOI: 10.1038/bjc.2015.201. View

20.

Groot M, Lee H . Sorting Mechanisms for MicroRNAs into Extracellular Vesicles and Their Associated Diseases. Cells. 2020; 9(4). PMC: 7226101. DOI: 10.3390/cells9041044. View